Synthesis and evaluation of a series of long-acting Glucagon-Like Peptide-1 (GLP-1) pentasaccharide conjugates for the treatment of type 2 diabetes

Nigel Irwin^*, Steven Patterson, Martin de Kort, R. Charlotte Moffett, Jeffry A.J. Wisse, Wim H.A. Dokter, Ebo S. Bos, Andre M.M. Miltenburg, Peter R. Flatt

^*Corresponding author for this work